Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US6620850B2 · kind B2 · utility
6Cited by
12References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2001 |
| Grant date | Sep 16, 2003 |
| Priority date | — |
| Expiry date | Sep 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/198
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention pertains to methods for treatment of neurological conditions related to, or which can be affected by, modulation of glutamate receptor (GluR) activity. The treatment can be either prophylactic in nature or to alleviate symptoms of such neurological conditions as ischemia, stroke, spinal cord injury and traumatic brain injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.